Unum Therapeutics - So Far, So Good...

It's been a little over 4 months since this clinical-stage biopharmaceutical company debuted on the NASDAQ, and its shares touched a new high yesterday.

from RTT - Biotech https://ift.tt/2MxZxlW
via IFTTT